On June 16, 2020 Affimed N.V. (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported that it will release first quarter 2020 results on Tuesday, June 23, 2020 and host a conference call at 8:30 a.m. EDT to discuss financial results and recent corporate developments (Press release, Affimed, JUN 16, 2020, View Source [SID1234561142]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference call will be available via phone and webcast. To access the first quarter results call, please dial +1-646-741-3167 for U.S. callers, or +44 (0) 2071 928338 for international callers, and reference conference ID 8594214 approximately 15 minutes prior to the call.

To access the live audio webcast of the conference call please visit the "Investors" section of company’s website at View Source A replay of the call will be archived on the Affimed website for 30 days after the call.

BMO Conference Participation
Affimed also announced that its Chief Executive Officer, Dr. Adi Hoess, will participate in a fireside chat at the 2020 BMO Prescriptions for Success Healthcare Conference on Tuesday, June 23rd, at 1:30 p.m. EDT.
A live webcast of the fireside chat will be available on the "Investors" section of the company’s website at View Source A replay of the fireside chat will be archived on the Affimed website for 30 days following the event.